Evidence map›Paper›PMID 28670966›Full record

Observational studyAIDS research and human retroviruses2018

Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.

Maximilian Muenchhoff, Michael Healy, Ravesh Singh, Julia Roider, Andreas Groll, Chirjeev Kindra, Thobekile Sibaya, Angeline Moonsamy, Callum McGregor, Michelle Q Phan and 9 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in AIDS research and human retroviruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 5 countries.

Maximilian Muenchhoff1 Department of Paediatrics, University of Oxford , Peter Medawar Building for Pathogen Research, Oxford, United Kingdom .
Michael Healy5 Division of Infectious Diseases, Department of Medicine, Columbia University , New York, New York.
Ravesh Singh2 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
Julia Roider1 Department of Paediatrics, University of Oxford , Peter Medawar Building for Pathogen Research, Oxford, United Kingdom .
Andreas Groll7 Department of Mathematics, Ludwig-Maximilians-University of Munich , Munich, Germany .
Chirjeev Kindra8 King Edward VIII Hospital , Durban, South Africa .
Thobekile Sibaya8 King Edward VIII Hospital , Durban, South Africa .
Angeline Moonsamy2 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
Callum McGregor1 Department of Paediatrics, University of Oxford , Peter Medawar Building for Pathogen Research, Oxford, United Kingdom .
Michelle Q Phan5 Division of Infectious Diseases, Department of Medicine, Columbia University , New York, New York.
Alejandro Palma5 Division of Infectious Diseases, Department of Medicine, Columbia University , New York, New York.
Henrik Kloverpris6 KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), Nelson R Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
Alasdair Leslie6 KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), Nelson R Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
Raziya Bobat8 King Edward VIII Hospital , Durban, South Africa .
Philip LaRussa12 Division of Infectious Diseases, Department of Pediatrics, Columbia University , New York, New York.
Thumbi Ndung'u2 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
Philip Goulder1 Department of Paediatrics, University of Oxford , Peter Medawar Building for Pathogen Research, Oxford, United Kingdom .
Magdalena E Sobieszczyk5 Division of Infectious Diseases, Department of Medicine, Columbia University , New York, New York.
Mohendran Archary8 King Edward VIII Hospital , Durban, South Africa .
University of KwaZulu-Natal · ZAColumbia University · USKing Edward VIII Hospital · ZAGerman Center for Infection Research · DELudwig-Maximilians-Universität München · DEMax Planck Institute for Infection Biology · DEMedawar Building for Pathogen Research · GBUniversity of Oxford · GB

Funding

Maximising Cure Potential in Paediatric HIV InfectionR01AI133673 · NIAID · UNIVERSITY OF OXFORD · PI GOULDER, PHILIP J · 2017 to 2021
$1.4M
NIAID NIH HHS R01 AI133673Wellcome Trust WT104748MA
6 · The paper itself

Abstract

This observational study aimed to describe immunopathogenesis and treatment outcomes in children with and without severe acute malnutrition (SAM) and HIV-infection. We studied markers of microbial translocation (16sDNA), intestinal damage (iFABP), monocyte activation (sCD14), T-cell activation (CD38, HLA-DR) and immune exhaustion (PD1) in 32 HIV-infected children with and 41 HIV-infected children without SAM prior to initiation of antiretroviral therapy (ART) and cross-sectionally compared these children to 15 HIV-uninfected children with and 19 HIV-uninfected children without SAM. We then prospectively measured these markers and correlated them to treatment outcomes in the HIV-infected children at 48 weeks following initiation of ART. Plasma levels of 16sDNA, iFABP and sCD14 were measured by quantitative real time PCR, ELISA and Luminex, respectively. T cell phenotype markers were measured by flow cytometry. Multiple regression analysis was performed using generalized linear models (GLMs) and the least absolute shrinkage and selection operator (LASSO) approach for variable selection. Microbial translocation, T cell activation and exhaustion were increased in HIV-uninfected children with SAM compared to HIV-uninfected children without SAM. In HIV-infected children microbial translocation, immune activation, and exhaustion was strongly increased but did not differ by SAM-status. SAM was associated with increased mortality rates early after ART initiation. Malnutrition, age, microbial translocation, monocyte, and CD8 T cell activation were independently associated with decreased rates of CD4% immune recovery after 48 weeks of ART. SAM is associated with increased microbial translocation, immune activation, and immune exhaustion in HIV-uninfected children and with worse prognosis and impaired immune recovery in HIV-infected children on ART.

Indexed as

Antiretroviral Therapy, Highly ActiveAcute DiseaseBacterial TranslocationBiomarkersCD4 Lymphocyte CountChildChild, PreschoolCross-Sectional StudiesFemaleFlow CytometryHIV-1HIV InfectionsHumansInfantLymphocyte ActivationMaleBiomarkersantiretroviral therapyimmune activationimmune exhaustionmalnutritionmicrobial translocationpediatric HIV

Identifiers

PMID28670966
PMCPMC5771534
OpenAlexW2733688339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.